Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 01 Mar 2023
Researchers at the University of East Anglia are on the verge of developing a new generation of cancer treatment. looking to the future...
Read Full NewsAmong 117 patients, breath-hold ventilation did not improve strict diagnostic yield vs conventional (86.8% vs 92.2%) in robotic bronchoscopy.
An epileptologist at Cleveland Clinic discussed findings from a recently published study of lifestyle interventions in epilepsy and why these approaches should complement rather than replace antiseizure medications.
Biopsy Scarring and Pegcetacoplan Response in C3G, With Carla Nester, MD
1.
Similar survival seen with simple versus radical hysterectomy for cervical cancer
2.
Despite Medicare Coverage, Cancer Genomic Testing Still Low
3.
A Surgical First for Removal of an Appendiceal Neoplasm
4.
Long-Acting Interferon Therapy Approved for ET
5.
fresh E. Coli Outbreak: ECMO Redefining Death and Bringing Universal Blood One Step Nearer.
1.
Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine
2.
Menstrual Blood Changes in Iron-Deficiency States: Clinical Insights and Evidence-Based Management
3.
Blastic Plasmacytoid Dendritic Cell Neoplasm and the Dawn of AI-powered Diagnostics
4.
Cracking Oncology Drug Resistance: New Strategies to Overcome Challenges in Modern Cancer Therapy
5.
Evidence-Based Approaches in Hematology for Modern Medicine
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
3.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
4.
When Unexplained Bruising May Require Blood Testing
5.
Cancer screening: Test that can help detect cancer early
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge